Correction to: Sleep disturbances in craniopharyngioma: a challenging diagnosis
(Source: Journal of Neurology)
Source: Journal of Neurology - October 13, 2021 Category: Neurology Source Type: research

ASCO 2021: Highlights in central nervous system tumors
SummaryMore than 140 abstracts were presented in the Central Nervous System Tumors track during the 2021 American Society of Clinical Oncology (ASCO) virtual meeting. Here, we review our personal highlights of the presented data. In rare entities such as papillary craniopharyngioma and neurotrophic tyrocine receptor kinase (NTRK)-fusion-positive tumors, promising data on targeted therapies were reported. In addition, early data on olaparib in high-grade glioma and combinational immunotherapy approaches will be briefly reviewed. Furthermore, the eagerly awaited results of the EORTC-1709 phase  III trial on the pan-proteaso...
Source: Memo - Magazine of European Medical Oncology - October 11, 2021 Category: Cancer & Oncology Source Type: research

Tuberculoma mimicking postoperative VP shunt seeding of craniopharyngioma: A rare case report
CONCLUSION: Tuberculoma should always be considered as one of the differential diagnoses along with primary and secondary intracranial neoplasm, particularly in developing and TB endemic countries, and inpatient with immunocompromised state.PMID:34621565 | PMC:PMC8492417 | DOI:10.25259/SNI_606_2021 (Source: Surgical Neurology International)
Source: Surgical Neurology International - October 8, 2021 Category: Neurosurgery Authors: Ahmad Data Dariansyah Wihasto Suryaningtyas Muhammad Arifin Parenrengi Source Type: research